<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link href="style.css" rel="stylesheet" type="text/css" />
<title>Lili Qin Research</title>
</head>
    
<body id="research">
<div id="container">
<div id="head">
    <h1><a href="index.html">LILI QIN</a></h1>
    <p>M.D., Ph.D.</p>
</div>
<div id="navi">
    <ul id="left-menu" class="menu-ul">
        <li><a href="index.html">HOME
                <p>About me</p>
            </a></li>
        <li><a href="research.html">RESEARCH
                <p>Professional work</p>
            </a></li>
        <li><a href="http://www.liliqin.com/articles/">ARTICLES
                <p>Professional thinking</p>
            </a></li>
        <li><a href="contact.html">CONTACT
                <p>Keep in touch</p>
            </a></li>
    </ul>
    <ul id="right-menu" class="menu-ul">
        <li><a href="http://ccr.cancer.gov/labs/lab.asp?labid=98" target="_blank">LBMB
                <p>NIH/NCI</p>
            </a></li>
        <li><a href="http://sklmo.org.cn/" target="_blank">SKLMO
                <p>CAMS&amp;PUMC</p>
            </a></li>
    </ul>
</div>
<!-- #EndLibraryItem --><div id="main" class="content">
    <P class="highlight">In the Ph.D. program,  Lili Qin participated in two research projects.  In an immunological 
        project, she prepared the polyclonal and monoclonal antibodies  against human cardiac troponin-I (cTn-I) by 
        herself and assisted in developing the enzyme-linked  immunosorbent assay which could be used in routine 
        clinical test of myocardial infarction (MI). In her dissertation research, she focused on the molecular 
        mechanism  through which Aurora-A, an oncogenic protein, promotes tumorigenesis. They screened the downstream 
        targets of Aurora-A, and then  concentrated on how Aurora-A  regulates Cyclin B1. </P>
    <p class="highlight">Please find a brief description of that work here.</p>
    <hr />
    <p id="aurora-a" class="highlight">The molecular mechanism of Aurora-A in tumorigenesis, 03/2006-09/2008</p>
    <p class="quote">State Key Laboratory of Molecular Oncology (<a href="http://sklmo.org.cn/">SKLMO</a>), Cancer 
        Institute &amp; Hospital (<a href="http://www.cicams.ac.cn/">CICAMS</a>), Chinese Academy of Medical Sciences 
        and Peking Union  Medical College  (<a href="http://www.pumc.edu.cn">PUMC</a>), Beijing, China</p>
    <p><span class="highlight">Summary:</span> The  mitotic regulator Aurora-A is an oncogenic protein that is 
        over-expressed in  many types of human tumors. This research focuses on the underlying mechanism  through 
        which Aurora-A  promotes tumorigenesis. In Aim 1, we will screen the downstream targets of Aurora-A. We 
        found that Aurora-A induces expression  changes of many proteins implicated in signaling pathways of cell 
        cycle control  and apoptosis. In Aim 2, we will concentrate on the molecular mechanism of Aurora-A in cell 
        cycle  control and in tumorigenesis. We found that overexpression of Aurora-A causes an elevation of Cyclin 
        B1  expression. Cyclin B1 degradation is delayed in Aurora-A  over-expressing cells, which depends on Aurora-A 
        kinase activity. In contrast, Aurora-A RNAi enhances Cyclin B1 degradation. Furthermore, we found that Aurora-A 
        overexpression reduces the  interaction of Cyclin B1 with APC subunits.  In human esophageal squamous  cell 
        carcinomas (ESCC), overexpression of Aurora-A  was correlated with deregulated expression of Cyclin B1. Taken
        together, these findings  suggest that overexpression of Aurora-A  may stabilize Cyclin B1 through inhibiting 
        its Ubiquitin-mediated degradation. Meanwhile, we found that Aurora-A interacts with Cyclin B1. Then the  
        interaction domains and the role of Aurora-A  kinase activity in the interaction were investigated. These 
        results may provide new insight into the mechanism of how  deregulated Aurora-A contributes to genomic 
        instability and carcinogenesis.</p>
    <p><span class="highlight">Skills and Abilities:</span><br />
        * Cell culture and treatment<br />
        * Protein purification and analysis (SDS-PAGE; Western Blotting)<br />
        * Immunological techniques (IF; IHC)<br />
        * Protein-protein interaction (IP; Pull-down assay)<br />
        * Preparation and analysis of RNA (PCR; RT-PCR; agarose gel  electrophoresis)<br />
        * Recombinant DNA techniques (Preparation  of plasmid DNA; Mutagenesis of cloned DNA; Enzymatic manipulation 
        of DNA; cDNA  cloning; Recombinant protein expression in <em>E. coli </em>and eukaryotic cells;  Transformation; 
        Transfection)<br />
        * Applications of computer (Primier5; SPSS; SigmaPlot; QuantityOne;  EndNote)</p>
    <hr />
    <p id="elisa" class="highlight">The Enzyme-Linked-Immunosorbent Assay for cardiac  troponin-I, 09/2004-07/2005</p>
    <p class="quote">Institute of  Radiation Medicine, Chinese Academy  of Medical Sciences and Peking Union Medical  
        College (<a href="http://www.pumc.edu.cn/">PUMC</a>), Tianjin, China</p>
    <p><span class="highlight">Summary:</span> To improve the sensitivity  and specificity of biochemical markers of 
        myocardial infarction (MI), monoclonal  antibodies against human cardiac troponin-I (cTn-I) are widely used to 
        measure cTn-I  in serum. In this project, we prepared polyclonal and monoclonal antibodies and  developed the 
        enzyme-linked immunosorbent  assay for  cTn-I measurement using  monoclonal antibody. The results proved to be 
        appropriate for routine clinical test  and scientific research with broad application prospects.</p>
    <p><span class="highlight">Skills and Abilities:</span><br />
        * Cell culture<br />
        * Polypeptide synthesis<br />
        * Animal manipulation; Antiserum generation and monoclonal antibody  isolation <br />
        * Hybridoma technology<br />
        * Protein  immunological assay (ELISA)<br />
        * Protein  purification and analysis (SDS-PAGE)</p>
</div>
<div id="side-bar">
    <div class="side-item">
        <h2>QUICK LINKS</h2>
        <div class="content">
            <ul>
                <li><a href="#aurora-a">The molecular mechanism of Aurora-A in tumorigenesis</a></li>
                <p>The underlying mechanism  through which Aurora-A  promotes tumorigenesis</p>
                <li><a href="#elisa">The ELISA for cTn-I</a></li>
                <p>Develop the ELISA for cTn-I measurement using  monoclonal antibody</p>
            </ul>
        </div>
    </div>
</div>
<div id="foot">
    <p>Copyright 2008-2010, Lili Qin, All rights reserved.</p>
    <div id="counter">
        <!-- Start of StatCounter Code -->
        <script type="text/javascript">
            var sc_project=4672130; 
            var sc_invisible=0; 
            var sc_partition=46; 
            var sc_click_stat=1; 
            var sc_security="8b706415"; 
        </script>
        <script type="text/javascript"
        src="http://www.statcounter.com/counter/counter.js"></script>
        <noscript>
            <div class="statcounter">
                <a title="counter" href="http://www.statcounter.com/" target="_blank"> 
                    <img class="statcounter"
                         src="http://c.statcounter.com/4672130/0/8b706415/0/"
                         alt="counter" ></a></div>
        </noscript>
        <!-- End of StatCounter Code -->
    </div>
    <ul class="menu-ul-sample">
        <li><a href="index.html">Home</a></li>
        <li><a href="research.html">Research</a></li>
        <li><a href="http://www.liliqin.com/articles/">Articles</a></li>
        <li><a href="contact.html">Contact</a></li>
    </ul>
</div>
</div>
</body>
</html>
